After a mean follow-up of 1811 months , 347 patients ( 66.2 % ) achieved DAS28 remission ; 323 were randomised to one of two dose regimens : etanercept 25 weekly ( group A , 159 patients ) and etanercept 25 mg bi-weekly ( group B , 164 patients ) .